Delivery Technology
Intranasal Ondansetron Shows IV-Comparable PK in Preclinical Study
The intranasal delivery route could expand non-injectable antiemetic options; human PK data expected by late 2026.
The intranasal delivery route could expand non-injectable antiemetic options; human PK data expected by late 2026.